Anti-fibrotic Treatment for Pulmonary Fibrosis Induced by COVID-19: A Case Presentation

• DOI: 10.5152/tjar.2021.20450
• Publication Date: 2021-06-02T12:34:29Z
• Authors: Bahar Sakizci Uyar; Kerem Ensarioglu; ; Bahar Kurt; ; Derya Ozkan; ; Serra Ozbal Gunes
• Keywords: Presentation (obstetrics); Case presentation; 2019-20 coronavirus outbreak

Coronavirus disease 19 infection clinical presentation varies from asymptomatic cases to acute respiratory distress syndromes.In some cases, pulmonary fibrosis is observed after or during the disease.Pirfenidone an agent approved for treatment of idiopathic fibrosis.Here we report a patient treated with pirfenidone related coronavirus 19.